Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Ketteler

Showing results (81-90 of 220) with videos related to

Pageof 22
Sort By:
Clinical Nuclear Medicine|January 24, 2002
Skeletal scintigraphy in acquired adult Fanconi syndromeVincent M Brandenburg, Markus Ketteler, Ursula Blum, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 6, 2006
Unclear fever 7 weeks after renal transplantation in a 56-year-old patientAnne Guetgemann, Vincent M Brandenburg, Markus Ketteler, et al.
Pediatric Nephrology (Berlin, Germany)|April 28, 2010
Vitamin D, chronic kidney disease and survival: a pluripotent hormone or just another bone drug?Patrick H Biggar, Orfeas Liangos, Holger Fey, et al.
Journal of Medical Economics|July 10, 2013
Comparative cost analysis of management of secondary hyperparathyroidism with paricalcitol or cinacalcet with low-dose vitamin D in hemodialysis patientsAmit Sharma, Markus Ketteler, Thomas S Marshall, et al.
Kidney & Blood Pressure Research|November 22, 2017
Impact of an in-Hospital Patient Education Program on Choice of Renal Replacement Modality in Unplanned Dialysis InitiationMoritz Schanz, Markus Ketteler, Markus Heck, et al.
Blood Purification|September 11, 2002
Novel insights into uremic vascular calcification: role of matrix Gla protein and alpha-2-Heremans Schmid glycoprotein/fetuinMarkus Ketteler, Cees Vermeer, Christoph Wanner, et al.
Kidney & Blood Pressure Research|November 15, 2021
Peritoneal Expression of SGLT-2, GLUT1, and GLUT3 in Peritoneal Dialysis PatientsSeverin Schricker, Tina Oberacker, Peter Fritz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 7, 2014
Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT studyMario Cozzolino, Markus Ketteler, Kevin J Martin, et al.
Antioxidants (Basel, Switzerland)|June 24, 2022
Enhanced Oxidative DNA-Damage in Peritoneal Dialysis Patients via the TXNIP/TRX AxisTina Oberacker, Peter Fritz, Moritz Schanz, et al.
Plos One|February 18, 2017
Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data from the German Calciphylaxis RegistryHansjörg Rothe, Vincent Brandenburg, Margot Haun, et al.
Pageof 22

Showing results (81-90 of 220) with videos related to

Sort By:
Pageof 22
Clinical Nuclear Medicine|January 24, 2002
Skeletal scintigraphy in acquired adult Fanconi syndromeVincent M Brandenburg, Markus Ketteler, Ursula Blum, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 6, 2006
Unclear fever 7 weeks after renal transplantation in a 56-year-old patientAnne Guetgemann, Vincent M Brandenburg, Markus Ketteler, et al.
Pediatric Nephrology (Berlin, Germany)|April 28, 2010
Vitamin D, chronic kidney disease and survival: a pluripotent hormone or just another bone drug?Patrick H Biggar, Orfeas Liangos, Holger Fey, et al.
Journal of Medical Economics|July 10, 2013
Comparative cost analysis of management of secondary hyperparathyroidism with paricalcitol or cinacalcet with low-dose vitamin D in hemodialysis patientsAmit Sharma, Markus Ketteler, Thomas S Marshall, et al.
Kidney & Blood Pressure Research|November 22, 2017
Impact of an in-Hospital Patient Education Program on Choice of Renal Replacement Modality in Unplanned Dialysis InitiationMoritz Schanz, Markus Ketteler, Markus Heck, et al.
Blood Purification|September 11, 2002
Novel insights into uremic vascular calcification: role of matrix Gla protein and alpha-2-Heremans Schmid glycoprotein/fetuinMarkus Ketteler, Cees Vermeer, Christoph Wanner, et al.
Kidney & Blood Pressure Research|November 15, 2021
Peritoneal Expression of SGLT-2, GLUT1, and GLUT3 in Peritoneal Dialysis PatientsSeverin Schricker, Tina Oberacker, Peter Fritz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 7, 2014
Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT studyMario Cozzolino, Markus Ketteler, Kevin J Martin, et al.
Antioxidants (Basel, Switzerland)|June 24, 2022
Enhanced Oxidative DNA-Damage in Peritoneal Dialysis Patients via the TXNIP/TRX AxisTina Oberacker, Peter Fritz, Moritz Schanz, et al.
Plos One|February 18, 2017
Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data from the German Calciphylaxis RegistryHansjörg Rothe, Vincent Brandenburg, Margot Haun, et al.
Pageof 22